Largest biotech by net assets

Shareholders' equity at the end of the latest fiscal year: what the company owns less what it owes. A negative figure means it owes more than it owns.

Gilead Sciences leads the 24 biotech ranked by net assets, at DKK 154.5B, ahead of BioNTech (DKK 145.2B) and Biogen (DKK 124.3B). Figures as of 18 Nov 2026, 14:43 UTC, from Yahoo Finance quotes.

Key facts

Companies ranked
24
First
Gilead SciencesDKK 154.5B
Median
DKK 13.7B
Combined market value
DKK 5.77T
Countries
5

Market values as of .

Largest biotech by net assets
#CompanyNet assets ↓Market capPriceToday1 yearPrice, 30 daysCountry
1Gilead SciencesGILD · Health CareDKK 154.5BDKK 1.43TDKK 1,154.93 0.34% down 33% up United States
2BioNTechBNTX · Health CareDKK 145.2BDKK 143.6BDKK 579.34 0.30% up 16% down Germany
3BiogenBIIB · Health CareDKK 124.3BDKK 253.4BDKK 1,714.01 0.41% up 49% up United States
4AmgenAMGN · Health CareDKK 58.9BDKK 1.67TDKK 3,082.53 1.10% down 34% up United States
5ModernaMRNA · Health CareDKK 58.9BDKK 571.2BDKK 1,411.80 0.30% up 755% up United States
6argenxARGX · Health CareDKK 49.8BDKK 411BDKK 6,535.53 1.34% up 4% up Belgium
7QiagenQGEN · Health CareDKK 25.7BDKK 69.9BDKK 338.42 0.06% down 12% up Netherlands
8Neurocrine BiosciencesNBIX · Health CareDKK 22.1BDKK 114.1BDKK 1,127.16 0.19% down 20% up United States
9VaxcytePCVX · Health CareDKK 18.3BDKK 63.8BDKK 403.11 0.29% down 22% up United States
10ExelixisEXEL · Health CareDKK 14.7BDKK 113.9BDKK 466.76 0.11% up 63% up United States
11Bio-TechneTECH · Health CareDKK 14.3BDKK 77.8BDKK 495.00 0.13% up 26% up United States
12RepligenRGEN · Health CareDKK 14.3BDKK 74BDKK 1,157.68 4.87% up 5% up United States
13CRISPR TherapeuticsCRSP · Health CareDKK 13.1BDKK 27.7BDKK 285.86 4.60% up 21% down Switzerland
14Revolution MedicinesRVMD · Health CareDKK 11.1BDKK 237.7BDKK 1,099.15 0.74% down 131% up United States
15Kymera TherapeuticsKYMR · Health CareDKK 10.8BDKK 71.3BDKK 835.63 1.03% up 87% up United States
16Krystal BiotechKRYS · Health CareDKK 8.3BDKK 61BDKK 2,058.63 1.31% up 46% up United States
17ImmunovantIMVT · Health CareDKK 5.8BDKK 47.2BDKK 228.15 0.93% up 43% up United States
18CG OncologyCGON · Health CareDKK 5.1BDKK 48.3BDKK 540.30 0.56% up 85% up United States
19Twist BioscienceTWST · Health CareDKK 3.2BDKK 52.6BDKK 771.31 1.18% up 340% up United States
20Scholar Rock HoldingSRRK · Health CareDKK 1.7BDKK 38.7BDKK 317.25 3.39% up 14% up United States
21Adaptive BiotechnologiesADPT · Health CareDKK 1.5BDKK 31.7BDKK 195.75 0.95% up 88% up United States
22Kodiak SciencesKOD · Health CareDKK 1.1BDKK 42.9BDKK 656.28 0.39% down 396% up United States
23Halozyme TherapeuticsHALO · Health CareDKK 332.3MDKK 74.7BDKK 654.96 0.27% up 37% up United States
24ImmunityBioIBRX · Health Care-DKK 3.4BDKK 45BDKK 42.34 0.64% down 193% up United States

Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.

Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Net assets is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Sums are converted from US dollars at today's exchange rate (1 USD = 6.8065 DKK).

Questions and answers

Which biotech rank first by net assets?

Gilead Sciences (DKK 154.5B), BioNTech (DKK 145.2B) and Biogen (DKK 124.3B) are the top three of the 24 biotech ranked by net assets as of 18 Nov 2026, 14:43 UTC.

How many biotech are in this ranking?

24 are ranked by net assets.

What are these biotech worth together?

The 24 biotech ranked by net assets have a combined market value of DKK 5.77T as of 18 Nov 2026, 14:43 UTC.

What does ranking by net assets measure?

Shareholders' equity at the end of the latest fiscal year: what the company owns less what it owes. A negative figure means it owes more than it owns.

Cite this page

Funkfolio, “Largest biotech by net assets”, data as of 18 November 2026. https://funkfolio.com/companies/category/biotech?by=net-assets

Underlying data: Yahoo Finance; SEC EDGAR.